XPhyto Therapeutics (XPHY.C) announced today that it has signed a definitive agreement for the acquisition of 3a-Diagnostics GmhB, Frickenhausen, Germany, XPhyto’s exclusive diagnostic development partner. Read full article here: https://equity.guru/2021/07/xphyto-therapeutics-xphy-c-signs-acquisition-agreement-with-3a-diagnostics-enters-biosensor-market/
![](https://e4njohordzs.exactdn.com/wp-content/uploads/2021/07/mqdefault-3-1.webp?strip=all&lossy=1&ssl=1&fit=320%2C180)